MPM BIOVENTURES 2018, L.P. sold 2.0% of their position (86.48K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $617.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/3/2026ACC: 0001231919-26-001144
10% Owner
Since Oct 2021
-86.48K
Net shares
Net seller
$617.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
86.48K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−29.09K
Price / share
$7.06
Trade value
$205.36K
% of position
0.7%
9/1/2026
4.23M→4.20M
Common Stock
Indirect
Shares
−25.13K
Price / share
$7.19
Trade value
$180.69K
% of position
0.6%
9/2/2026
4.20M→4.18M
Common Stock
Indirect
Shares
−32.26K
Price / share
$7.17
Trade value
$231.33K
% of position
0.8%
9/3/2026
4.18M→4.14M
Total
Net shares
−86.48K
Net value
-$617.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/1/2026 | S · Sale | −29.09K | $7.06 | $205.36K | 0.7% | 4.23M | 4.20M |
| Common Stock Indirect | 9/2/2026 | S · Sale | −25.13K | $7.19 | $180.69K | 0.6% | 4.20M | 4.18M |
| Common Stock Indirect | 9/3/2026 | S · Sale | −32.26K | $7.17 | $231.33K | 0.8% | 4.18M | 4.14M |
| Total | −86.48K | -$617.38K | ||||||
Derivative Transactions0
No derivative transactions reported